Ixabepilone + Capecitabine Interaction
Minorinteraction on record
Description
No clinically meaningful pharmacokinetic differences observed. Ixabepilone Cmax decreased 19%, capecitabine Cmax decreased 27%, 5-fluorouracil AUC increased 14%; interaction not clinically significant given supported efficacy data.
Mechanism
Mutual pharmacokinetic effects with minimal clinical impact
Source: NLP:ixabepilone